about
Venous thromboembolism prophylaxis for acute spinal cord injury patientsA novel allosteric pathway of thrombin inhibition: Exosite II mediated potent inhibition of thrombin by chemo-enzymatic, sulfated dehydropolymers of 4-hydroxycinnamic acidsTherapeutic potential and health benefits of Sargassum speciesA Simple Method for Discovering Druggable, Specific Glycosaminoglycan-Protein Systems. Elucidation of Key Principles from Heparin/Heparan Sulfate-Binding ProteinsFinding a needle in a haystack: development of a combinatorial virtual screening approach for identifying high specificity heparin/heparan sulfate sequence(s).Understanding Dermatan Sulfate-Heparin Cofactor II Interaction through Virtual Library ScreeningCharacterization of the plasma and blood anticoagulant potential of structurally and mechanistically novel oligomers of 4-hydroxycinnamic acidsDynamic affinity chromatography in the separation of sulfated lignins binding to thrombin.Designing nonsaccharide, allosteric activators of antithrombin for accelerated inhibition of factor Xa.Electronically Rich N-Substituted Tetrahydroisoquinoline 3-Carboxylic Acid Esters: Concise Synthesis and Conformational StudiesOn scaffold hopping: challenges in the discovery of sulfated small molecules as mimetics of glycosaminoglycans.Discovery of allosteric modulators of factor XIa by targeting hydrophobic domains adjacent to its heparin-binding site.Polysulfated trehalose as a novel anticoagulant agent with dual mode of action.The effects of marine carbohydrates and glycosylated compounds on human health.Investigation of the heparin-thrombin interaction by dynamic force spectroscopyPotent direct inhibitors of factor Xa based on the tetrahydroisoquinoline scaffold.Designing allosteric regulators of thrombin. Monosulfated benzofuran dimers selectively interact with Arg173 of exosite 2 to induce inhibition.A Hexasaccharide Containing Rare 2-O-Sulfate-Glucuronic Acid Residues Selectively Activates Heparin Cofactor II.Primary prophylaxis of venous thromboembolism in surgical patients.Marine derived polysaccharides for biomedical applications: chemical modification approaches.On designing non-saccharide, allosteric activators of antithrombin.Capillary electrophoretic study of small, highly sulfated, non-sugar molecules interacting with antithrombin.Developments in factor Xa inhibitors for the treatment of thromboembolic disorders.Elucidating the specificity of non-heparin-based conformational activators of antithrombin for factor Xa inhibition.Limitations of conventional anticoagulant therapy and the promises of non-heparin based conformational activators of antithrombin.Anticoagulant use in real time.Antithrombin-binding oligosaccharides: structural diversities in a unique function?
P2860
Q24239926-A9EC0063-F4BB-4D95-B9D9-58124BDC6E89Q24652951-B3B44A22-CE89-439B-9815-617BA04A0CD4Q28658760-51E2C09D-78E7-447F-B555-7703023EBDB0Q30380524-F9D7E2F4-E8D9-4164-870D-C9033B0133B4Q33246009-5893EDB2-A0E7-4755-B5A9-529F7DAFFCA5Q33690582-0E9E457F-494B-47BA-9A6E-6AB13E4C6C07Q33899404-43A0521F-B353-40EA-80A2-22897CDB42CAQ33905734-C116403C-F6E8-4429-A042-67F8E3EC4820Q33975255-4D7FF17E-010B-4E7E-903C-D660C6447074Q34292151-0DA1003B-15EB-4AC1-B492-A6100E1F32B3Q34481378-1B460004-EBBF-416D-884D-F20BA14FD03AQ34604052-6DBA6033-B5BE-4F6F-817B-D989B2E93610Q35239901-D5FE0441-3940-4AA6-B734-582A1CF7BFE4Q35381522-101D9502-E1A6-4832-96E6-19676002577AQ35434465-F308FB1C-8FCA-44FF-893E-CB8AD2BCE30DQ36129629-31C5DCC8-864C-41CB-800B-1D78642BC2B0Q36157083-AE5BC229-9643-4F06-B388-B3651B7C5F11Q36260763-A2800823-74BA-457E-882E-62CF7ABD2D6DQ37122818-988DE7B1-74B0-46DC-B8CA-7D55828FAB6EQ37284597-5126B0CC-8077-4E70-AA52-87F2E9E0B934Q37345593-E17EC826-9D80-47B0-ACB2-9F5463C46104Q37371255-3A535D74-D5DB-42D6-9499-1B0FB5D9CD38Q37646551-82E2600E-D5D8-49F0-8EB6-B0434F809E25Q37654381-D76CFCDD-08AF-4ADD-A256-0F2CCEDE69F9Q37997628-6290F972-7182-4B15-909F-B0D081EED7D5Q38062284-EAF940B1-DE8C-4D5F-9EF0-F3EEAED1EBB9Q38304819-730FC357-98DF-43FD-ACA2-1CE212179597
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
New antithrombin-based anticoagulants.
@ast
New antithrombin-based anticoagulants.
@en
type
label
New antithrombin-based anticoagulants.
@ast
New antithrombin-based anticoagulants.
@en
prefLabel
New antithrombin-based anticoagulants.
@ast
New antithrombin-based anticoagulants.
@en
P2860
P356
P1476
New antithrombin-based anticoagulants.
@en
P2093
Umesh R Desai
P2860
P304
P356
10.1002/MED.10058
P577
2004-03-01T00:00:00Z